Updates
-
Synthetic Genomics and Advaxis have developed a current good manufacturing practice (cGMP) synthetic biology suite to produce synthetic DNA constructs. The cGMP facility meets U.S. Food and ... Read more
-
S-1 and Platinol Combo Shows Promise Against Cervical Cancer, Phase 3 Trial Indicates
Adding S-1 to Platinol (cisplatin) chemotherapy improved cervical cancer patients’ response to treatment and lengthened the time it took for their disease to progress, according ... Read more -
Opdivo Showing Early Promise in Advanced Cervical Cancer Patients Enrolled in Phase 1/2 Trial
Preliminary data from a Phase 1/2 trial, presented at the American Society of Clinical Oncology Annual 2017 Annual Meeting, shows that Opdivo (nivolumab) monotherapy was ... Read more -
Experimental New Device May Allow for Easier Cervical Cancer Screening
A new device developed at Duke University aims to improve cervical cancer screening by replacing uncomfortable speculum exams and high-cost colposcopes with a device that ... Read more -
Patients Being Recruited for Phase 2 Trial of Keytruda and Chemoradiation in Cervical Cancer
Cervical cancer patients are being recruited for a Phase 2 clinical trial of a combination of Keytruda (pembrolizumab) and chemoradiation therapy. The randomized trial (NCT02635360) is ... Read more
-
Keytruda Shows Promise in People with Advanced Disease, Early Phase 2 Trial Results Show
Merck’s Keytruda (pembrolizumab) shows promise as a treatment for advanced, previously treated cervical squamous cell ... -
Chemotherapy Plus P53 Gene Therapy May Help Treat Locally Advanced Cervical Cancer
Locally advanced cervical cancer (LACC) may be treated with a combination of neoadjuvant chemotherapy (administered ... -
Cervical Cancer Screening Device Mía, by Mel-Mont Medical, Allows HPV Sampling at Home
A new diagnostic system by Mel-Mont Medical that allows women to collect cervical cell samples at home ... -
Cervical Cancer Patient Achieves Long-lasting Response to AXAL in Clinical Trial
One of nine cervical cancer patients treated with AXAL achieved a long-lasting partial response to the ... -
2 Doses of HPV Vaccine Protect Against Genital Warts, Study Finds, But Impact on Cancer Unknown
Two doses of the human papillomavirus (HPV) vaccine are enough to protect children, younger than ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Cervical Cancer News Forums
4 Additional LuViva Cervical Scan Systems Shipped to Bangladesh
News
Guided Therapeutics recently shipped four additional LuViva Advanced Cervical Scan systems to Bangladesh for the country’s cervical cancer screening program. Bangladesh will now receive a total of 12 LuVivas and more than 1,000 disposable Cervical Guides. Worldwide, there are around 2.6 ... Read more